Conserved residues Asp16 and Pro24 of TnaC-tRNAPro participate in tryptophan induction of Tna operon expression.
In Escherichia coli, interactions between the nascent TnaC-tRNA(Pro) peptidyl-tRNA and the translating ribosome create a tryptophan binding site in the ribosome where bound tryptophan inhibits TnaC-tRNA(Pro) cleavage. This inhibition delays ribosome release, thereby inhibiting Rho factor binding and action, resulting in increased tna operon transcription. Replacing Trp12 of TnaC with any other amino acid residue was previously shown to prevent tryptophan binding and induction of tna operon expression. Genome-wide comparisons of TnaC amino acid sequences identify Asp16 and Pro24, as well as Trp12, as highly conserved TnaC residues. Replacing these residues with other residues was previously shown to influence tryptophan induction of tna operon expression. In this study, in vitro analyses were performed to examine the potential roles of Asp16 and Pro24 in tna operon induction. Replacing Asp16 or Pro24 of TnaC of E. coli with other amino acids established that these residues are essential for free tryptophan binding and inhibition of TnaC-tRNA(Pro) cleavage at the peptidyl transferase center. Asp16 and Pro24 are in fact located in spatial positions corresponding to critical residues of AAP, another ribosome regulatory peptide. Sparsomycin-methylation protection studies further suggested that segments of 23S RNA were arranged differently in ribosomes bearing TnaCs with either the Asp16Ala or the Pro24Ala change. Thus, features of the amino acid sequence of TnaC of the nascent TnaC-tRNA(Pro) peptidyl-tRNA, in addition to the presence of Trp12, are necessary for the nascent peptide to create a tryptophan binding/inhibition site in the translating ribosome.
Cruz-Vera
Luis R
LR
Department of Biological Sciences, Stanford University, Stanford, CA 94305, USA.
Yanofsky
Charles
C
D019943:Amino Acid Substitution / Q000235:genetics; D001216:Asparagine / Q000235:genetics; D017124:Conserved Sequence; D004926:Escherichia coli / Q000502:physiology*; D029968:Escherichia coli Proteins / Q000235:genetics / Q000378:metabolism*; D015964:Gene Expression Regulation, Bacterial; D023061:Gene Order; D016297:Mutagenesis, Site-Directed; D009876:Operon; D011392:Proline / Q000235:genetics; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D012346:RNA, Transfer, Amino Acyl / Q000235:genetics / Q000378:metabolism*; D012361:RNA, Transfer, Pro / Q000378:metabolism*; D012234:Rho Factor / Q000378:metabolism; D012270:Ribosomes / Q000378:metabolism*; D017386:Sequence Homology, Amino Acid; D013033:Sparsomycin / Q000494:pharmacology; D014364:Tryptophan / Q000378:metabolism*
D029968:Escherichia coli Proteins; D011500:Protein Synthesis Inhibitors; D012346:RNA, Transfer, Amino Acyl; D012361:RNA, Transfer, Pro; D012234:Rho Factor; C019037:tRNA, peptidyl-; C081473:tnaC protein, E coli; D011691:Puromycin; D013033:Sparsomycin; D001216:Asparagine; D014364:Tryptophan; D011392:Proline